Pharmacology and Non-pharmacology Approaches in Reducing Children's Pain and Fear During Painful Procedures

March 26, 2024 updated by: Sherzad Khudeida Suleman, Uppsala University

Randomized Controlled Trial Examining the Effectiveness of Pharmacology and Non-pharmacology Approaches in Reducing Children's Pain and Fear During Painful Procedures

This study Will contribute in the knowledge of pediatric nurses during painful procedures such venipuncture

Study Overview

Status

Enrolling by invitation

Conditions

Detailed Description

Children frequently undergo unexpected and procedure-related pain while in hospital settings, leading to adverse emotional and psychological effects. The exposure to painful procedures, particularly venipuncture, commonly occurs in emergency units, upon admission, during hospital stays, or during follow-up visits. The mere act of inserting needles stands out as one of the most distressing medical procedures for children, resulting in frightening and upsetting experiences for both the children and their parents throughout the hospitalization period.

In the realm of pain management, interventions can generally be classified into pharmacological and non-pharmacological approaches. Within pharmacological interventions, local anesthetics play a key role in addressing needle-related pain. These anesthetics can permeate the cuticle and epidermal layers of intact skin, reaching the dermis where nerve endings are situated, thereby alleviating pain. Notably, a eutectic mixture of local anesthetics (EMLA) emulsion, composed of 25 mg lidocaine and 25 mg prilocaine per gram, has been explored in pediatric settings for managing venipuncture pain due to its effectiveness and minimally invasive nature.

On the non-pharmacological front, various strategies have been investigated for needle procedures in children, including distraction techniques, cognitive and behavioral therapy, hypnosis, and memory alteration. Among these interventions, distraction stands out as a straightforward method that can be promptly applied and requires minimal prior training. A systematic review has demonstrated the effectiveness of distraction in alleviating pain associated with needle-related procedures.

Study Type

Interventional

Enrollment (Estimated)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Erbil
      • Duhok, Erbil, Iraq, 42012
        • Sherzad Khudeida Suleman

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion:

School-aged 6-12 years old. Children who require PIVC.

Exclusion:

  1. Chronic diseases,
  2. Physical impairment,
  3. Disability contributes to difficult communication,
  4. Children of unsatisfied parents,
  5. Children with neurodevelopment delays,
  6. Cognitive impairment, hearing impairment, or visual impairment,
  7. Taking an analgesic within 6 hours, or those with a syncope history.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TICK-B
active distraction technique as non-pharmacology in treating children's pain and fear during venipuncture procedure.
TICK-B as art-based distraction
Experimental: TkTx-Cream
as Pharmacological approach will be use in managing children's pain and fear during venipuncture procedure.
TKTX-Cream as local anesthesia cream
Other Names:
  • Local anesthesia
Experimental: TICK-B and TkTx-C
Pharmacological approache and non-Pharmacological will be use in managing children's pain and fear during venipuncture procedure.
TICK-B and TkTx-C as combined intervention approche (pharmacology and non-pharmacology)
Other Names:
  • Combination approach
No Intervention: Control Group
No intervention will applied in this group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
severity of Pain
Time Frame: baseline, during, and immediately post-procedure.
Severity of pain will be assessed using Wong-Baker FACES Pain Rating Scale, a validated self-reporting tool widely utilized in clinical settings. Participants will be instructed to rate their pain on a scale from 0 (indicating no pain) to 10 (representing the worst imaginable pain). The Wong-Baker FACES Pain Rating Scale will be administered promptly after the completion of the procedure.
baseline, during, and immediately post-procedure.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fear
Time Frame: baseline, during, and immediately post-procedure.
level of fear will be assessed using the Child Fear Scale (CFS), a validated instrument designed to measure the level of fear in pediatric populations. Participants will be asked to express their feelings of fear related to the procedure through the Child Fear Scale.
baseline, during, and immediately post-procedure.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sherzad Suleman, MsC, Uppsala University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2023

Primary Completion (Estimated)

April 10, 2024

Study Completion (Estimated)

April 10, 2024

Study Registration Dates

First Submitted

February 16, 2024

First Submitted That Met QC Criteria

March 16, 2024

First Posted (Actual)

March 22, 2024

Study Record Updates

Last Update Posted (Actual)

March 28, 2024

Last Update Submitted That Met QC Criteria

March 26, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SherzadSH

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on TICK-B

Subscribe